Generics 17

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Sirolimus manufacturers

17 products found

Filters

17 products found

sirolimus

Oral solution 1 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #19624

Manufacturer usually replies in 8 days

sirolimus

Tablets 0.5 mg, 1 mg, 2 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #615

Manufacturer usually replies in 3 days

sirolimus

Tablets 0.5 mg, 1 mg, 2 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #18975

Manufacturer usually replies in 6 days

sirolimus

Tablets 10 mg, 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18530

Manufacturer usually replies in 4 days

sirolimus

Capsules 0,5mg, 1mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #1026

Manufacturer usually replies in 4 days

sirolimus

Capsules 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
GMP, WHO
Manufacturer #24869

Manufacturer usually replies in 3 days

sirolimus

Capsules 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20087

Manufacturer usually replies in 8 days

sirolimus

Tablets 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19670

Manufacturer usually replies in 8 days

sirolimus

Tablets 1mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Oman
GMP approvals
Oman
Manufacturer #11905
It is one of the first pharmaceutical companies to be situated on the southeastern coast of the Arabian peninsula. As a researched-based company, it is driven by innovation and quality, which are reflected in the world-class pharmaceuticals being manufactured in its various facilities. The company has manufacturing operations in more than 2 countries covering oral solids, liquids, dry powders for reconstitution, and sachets covering various therapeutics like cardiovascular, anti-diabetic, anti-infective, cough & cold, musculoskeletal, gastrointestinal, dermatology, CNS.

Manufacturer usually replies in 9 days

sirolimus

Tablets for oral solution 1 mg, 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19828

Manufacturer usually replies in 14 days

sirolimus

Tablets 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19639

Manufacturer usually replies in 12 days

sirolimus

Tablets 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20824

Manufacturer usually replies in 18 days

sirolimus

Tablets 0.5 mg, 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21324

Manufacturer usually replies in nan days

sirolimus

Tablets 0,5mg, 1mg, 2mg

Dossier type
CTD
Dossier status
Under development
Country of origin
European Union
Manufacturer #411

sirolimus

Tablets 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #30830

sirolimus

Tablets 0.5 mg, 1 mg, 2 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Manufacturer #31071

sirolimus

Tablets 0.5 mg, 1 mg, 2 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Manufacturer #31071
Sirolimus, also known as Rapamycin, is a medication that is from the class of drugs known as Immunosuppressants. It is administered to patients who have had a kidney transplant to prevent their body from rejecting the transplanted kidney. It is used in conjunction with other medications. It is also used in treatment for certain types of tumors, lung disease, and psoriasis. In its compound form, it is used to coat coronary stents. Sirolimus is sold under the name, Rapamune by Pfizer since 1999. Sirolimus is a bacterium, that was first isolated by Surendra Nath Sehgal in 1972 while collecting samples of a certain bacteria on the Easter Island and thus the original compound named Rapamycin after the original inhabitants of the island, the Rapa-nui. While initially developed as an anti-fungal agent, it was discovered that it had potent immunosuppressive and antiproliferative properties and later on approved for use in 1999 by the FDA. Then in May 2015, FDA approved Sirolimus for the treatment of a rare lung disorder called Lymphangioleiomyomatosis. Dosage Sirolimus comes as a tablet and a solution to be taken orally. It is usually taken once a day. The dosage is adjusted by the doctor based on the body response once every week or two. This medicine is to be taken exactly as prescribed by the doctor. It is available as an oral solution (1 mg/ml) and tablets (0.5, 1 and 2 mg). In kidney transplants, to prevent organ rejection, the first dose of 6 mg given soon after the transplant. The doctor will change the dose until the patient’s blood has enough Sirolimus. In the treatment of S-LAM, a dose of 2 mg is taken daily and after the doctor has tested for effect, the dosage is adjusted in order to achieve the desired levels of Sirolimus in the body. The cost of Sirolimus The price of Sirolimus varies vastly by the country and the drugmaker. According to a leading pharmacy, Sirolimus oral solution (1 mg/mL) costs $1,336 for a supply of 60 milliliters in the USA, whereas the price of 1mg tablet varies from 8 USD to 10 USD. In India the prices are significantly lower, starting at 0.7cent to 7 USD per tablet of 1mg. How does it work? The body rejects a new organ when the immune system attacks the new organ thinking of it as an invader. Sirolimus works through the weakening of the human immune system, which, in turn, helps the human body, accept the new organ as its own. It does this by attaching itself to a protein inside cells to make a 'complex', which it uses to block a protein called mTOR. mTOR regulates cell growth and proliferation and in the multiplication of white blood cells that attack the newly transplanted organ as an invader. The use of sirolimus reduces the number of white blood cells the body is producing to attack the organ, thus reducing the rejection and increasing chances of acceptance. Finding Sirolimus Manufacturers and Suppliers: The process of finding trusted Sirolimus manufacturers and Sirolimus suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Sirolimus. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily. Brands and manufacturers: Brands: Rapamune, Gd-sirolimus, Manufacturers: Pfizer, Wyeth, Cardinal health, Genmed A, Amneal, Greenstone LLC and American health packaging India : Biocon, Zydus, Panacea biotech Packagers: Cardinal Health, Hangzhou Zhongmei Huadong Pharmaceutical Co. Ltd., Lake Erie Medical and Surgical Supply,Patheon Inc,., Poli Industria Chimica SPA, Wyeth Pharmaceuticals